About us
Experts in single-cell science, -omics analytics, and AI.
Our new and emerging analytical device produces rich data-sets by measuring hundreds of parameters from millions of individual cells. The resulting single-cell data holds the information needed for early disease detection, but it requires sophisticated and innovative computational approaches in order to extract the relevant information.
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets. Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.
We are addressing this problem by developing artificial intelligence (AI) software for single-cell data analysis. The underlying best-in-class algorithms allow us to associate patterns in single-cell data with disease status.
We provide a powerful software solution (ScaiVision), unifying our AI technology for the global medical community and delivering it to those working in drug and diagnostic R&D.
Mission
Our mission is to advance precision medicine with single-cell technologies, artificial intelligence, and multiomics analysis.
Vision
To save lives by enabling precision medicine.
Our Team
Dr. Peter Nestorov
Peter holds a PhD in Genetics from the University of Basel and a degree in Biochemistry from the University of Tübingen. He has been working in the emerging single-cell analysis market since 2015 and this gave him the inspiration to start Scailyte as co-founder and CEO in 2017.
Dr. Corinne Solier
Chief Operating Officer
Corinne obtained a Masters in Engineering Sciences in Biotechnology and a PhD in Immunology from Université Paul Sabatier in Toulouse, France. She pursued postdoctoral studies at the City of Hope National Medical Center in the U.S.A. in the field of nuclear receptor biochemistry before joining Roche Pharmaceuticals. There, she held various positions in early research and development, intersecting with translational biomarker science, cutting-edge “omics” technologies and innovation. She joined Scailyte in 2021 as Chief Operating Officer.
Dr. Sarah Carl
Director Data Science
Sarah holds a PhD in Genetics from the University of Cambridge. She worked as a bioinformatician at the Friedrich Miescher Institute in Basel, Switzerland, for four years before joining Scailyte. Sarah joined Scailyte as a data scientist in 2018 and now serves as Director of Data Science.
Diana Stoycheva
Principal Expert Scientist
Diana is a principal scientist with a Masters in Molecular Biotechnology from the University of Heidelberg. She holds a PhD in immunology from HU Berlin and pursued postdoctoral studies in Immunology at the ETH Zurich. Diana’s strong scientific background reflects her personal passion for immunology, immuno-oncology and specifically cell therapies. She joined Scailyte in 2020, evaluating opportunities to apply our AI to new projects in immunology and immuno-oncology.
Anna Sumeray
Biotech startup CEO, member of the Scailyte Board of Directors
Anna is a global Biotech executive and entrepreneur with broad experience of defining and building successful businesses. Advisor and investor in biotech start-ups, pioneer and general manager of European launch projects and experienced business development leader and negotiator.
Prof. Dr. Michael Mueller, MD
Michael is a renowned gynecologist and gynecological oncologist, and managing director of the Women’s Health Clinic at the University Hospital of Bern (Inselspital). Prof. Mueller is supporting Scailyte as a clinical advisor and expert in endometriosis and women’s health.
Prof. Dr. Petter Brodin, MD
Petter is a pioneer in single-cell analysis and, advising Scailyte in immunology and the application of single-cell technologies for clinical research. Prof. Brodin is based at the Karolinska Institute in Sweden and heads a research group that focuses on systems-level analyses of the human immune system. Prof. Brodin is a consultant pediatrician working at the Karolinska University Hospital.
Prof. Dr. Tomas Kalina MD
Tomas is a physician and a cytometry expert currently leading a research group focused on disorders of adaptive immunity at the Charles University in Prague. Professor Kalina is supporting Scailyte as a clinical diagnostic advisor with his expertise in cytometry standardization.
Join the Scailyte team
Are you ready to help us transform biomedical research and healthcare? Please send us your CV, and your letter of motivation to join Scailyte, in an email to: careers@scailyte.com
Become part of something great.
To achieve our mission, we are looking for smart, passionate and dedicated individuals who share our values by dreaming big, to join our growing, energetic and fun team. We offer flexible working schedules and location.
Recent News
Meet Scailyte at BioTechX
Meet Scailyte at BioTechX at Booth #37 in Basel Congress Center from 8th to 10th November 2022.
Recent News
Scailyte closes Series A funding with a CHF 6 million investment
Scailyte has successfully finished the Series A funding raising CHF 6 million from a Swiss family of
Recent News
VACANCY: Internship in Women’s Health R&D
The internship in Women’s Health R&D will focus on our in vitro diagnostics development work in en
Recent News
Nilogen and Scailyte Are Joining Forces to Find the “Right” Treatment for Every Patient
Nilogen and Scailyte are joining forces to increase the success of cancer therapies in clinics and t
Recent News
Machine learning meets multi-omics for precision medicine
Bringing industry and academia together to discuss the potential impact of single-cell analytics pow
Recent News
Understanding Resistant to CAR-T Immunotherapy to Develop Better Next-generation Therapies
Register for Scailyte's webinar on "Understanding Resistant to CAR-T Immunotherapy to Develop Better
Recent News
VACANCY: Technical Lead / Product Owner for a clinical diagnostic software
Scailyte is a globally recognised spin-off from ETH Zürich and a pioneer in the field of single-cel
Recent News
VACANCY: Data Scientist in Biomarker Discovery
Scailyte is a globally recognized spin-off from ETH Zürich and a pioneer in the field of single-cel
Recent News
Meet Scailyte at BioTechX
Meet Scailyte at BioTechX at Booth #37 in Basel Congress Center from 8th to 10th November 2022.
Scailyte closes Series A funding with a CHF 6 million investment
Scailyte has successfully finished the Series A funding raising CHF 6 million from a Swiss family of
Recent News
VACANCY: Internship in Women’s Health R&D
The internship in Women’s Health R&D will focus on our in vitro diagnostics development work in en
Nilogen and Scailyte Are Joining Forces to Find the “Right” Treatment for Every Patient
Nilogen and Scailyte are joining forces to increase the success of cancer therapies in clinics and t
Recent News
Machine learning meets multi-omics for precision medicine
Bringing industry and academia together to discuss the potential impact of single-cell analytics pow
Understanding Resistant to CAR-T Immunotherapy to Develop Better Next-generation Therapies
Register for Scailyte's webinar on "Understanding Resistant to CAR-T Immunotherapy to Develop Better
Recent News
VACANCY: Technical Lead / Product Owner for a clinical diagnostic software
Scailyte is a globally recognised spin-off from ETH Zürich and a pioneer in the field of single-cel
VACANCY: Data Scientist in Biomarker Discovery
Scailyte is a globally recognized spin-off from ETH Zürich and a pioneer in the field of single-cel
Are you ready to help us transform biomedical research and healthcare? Please send us your CV, and your letter of motivation to join Scailyte, in an email to: careers@scailyte.com